Previous 10 | Next 10 |
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has been named to Great Place to Work’s 2020 Best Workplaces for Parents list, which highlights companies that have created consistently positive experiences for working parents, especially in light of the COVID-...
- Company has provided more than $3.7 million to COVID-19 response and relief efforts - Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has provided $1.2 million in additional funding to U.S and international organizations to support COVID-1...
- Horizon to use ENHANZE ® subcutaneous delivery technology for TEPEZZA ® (teprotumumab-trbw) - Horizon Therapeutics plc (Nasdaq: HZNP) and Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced a global collaboration and license agreement that gives Horizo...
John Paulson’s 13F portfolio value increased from $3.13B to $3.21B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and SPDR Gold ETF. The stake in Endo International plc was increased substantially during the quarter. ...
Horizon Therapeutics plc (Nasdaq: HZNP) has been named to the National Association for Business Resources’ 2020 list of Best and Brightest Companies to Work For in the Nation . Horizon is one of 151 winning organizations from across the United States out of 1,100 nominations....
-- TED Today, a daily, online video series shares motivational stories from the TED community and useful resources to help people along their TED journey -- Today marks the start of the first-ever Thyroid Eye Disease (TED) Awareness Week, taking place from Nov. 16 to Nov. 20...
-- Presentation during American Academy of Ophthalmology Annual Meeting (AAO 2020 Virtual) demonstrates clinical improvement in the less severe eye -- -- Additional data from OPTIC 48-week follow-up study and OPTIC-X extension trial, including findings showing that the majorit...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Tim Walbert, chairman, president and chief executive officer, has been honored with the 2020 RARE Champion of Hope Industry Partner award by Global Genes, a nonprofit organization that connects, empowers and inspires the rare ...
Image source: The Motley Fool. Horizon Therapeutics PLC (NASDAQ: HZNP) Q3 2020 Earnings Call Nov 2, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Horizon Therapeutics PLC (HZNP) Q3 2020 Earnings Call Transcript
Data from randomized controlled clinical trial evaluating Horizon Therapeutics' ([[HZNP]] -2.4%) Krystexxa (pegloticase injection) concomitantly used with an immunomodulator, shows improved response rates as compared to Krystexxa monotherapy.19/22 (86.4%) of patients ...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...